X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-07-06 | SGHT | Sight Sciences, Inc. | Hayden Jeremy B. | GC | S - Sale | $5.51 | -12,733 | 357,037 | -3% | -$70,133 | ||||||
2026-07-02 | SGHT | Sight Sciences, Inc. | Rodberg James | CFO | S - Sale | $5.36 | -6,902 | 224,037 | -3% | -$36,995 | ||||||
2026-07-06 | SGHT | Sight Sciences, Inc. | Badawi David | CTO | S - Sale | $5.51 | -7,418 | 1,982,872 | 0% | -$40,858 | ||||||
2026-07-01 | SGHT | Sight Sciences, Inc. | Taylor Brenton | EVP, Operations, R, D | S - Sale | $5.42 | -2,829 | 264,978 | -1% | -$15,333 | ||||||
2026-07-02 | SGHT | Sight Sciences, Inc. | Bauerlein Alison | COO | S - Sale | $5.36 | -24,184 | 664,709 | -4% | -$129,626 | ||||||
2026-07-01 | SGHT | Sight Sciences, Inc. | Badawi Paul | Pres, CEO, 10% | S - Sale | $5.42 | -28,684 | 6,122,472 | 0% | -$155,467 | ||||||
2026-07-02 | SIBN | Si-Bone, Inc. | Pisetsky Michael A. | SVP, Ops, Adm, Chief Legal Ofr | S - Sale | $16.71 | -3,134 | 277,375 | -1% | -$52,375 | ||||||
2026-07-02 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $16.77 | -3,317 | 256,560 | -1% | -$55,627 | ||||||
2026-07-02 | IRTC | Irhythm Holdings, Inc. | Turakhia Minang | CHIEF MED, SCI OFCR EVP ADVTEC | S - Sale | $124.71 | -1,423 | 53,620 | -3% | -$177,462 | ||||||
2026-07-02 | IRTC | Irhythm Holdings, Inc. | Freeman Sean Clinton | EVP, Strategy, Corp Devt | S - Sale | $124.71 | -918 | 13,641 | -6% | -$114,484 | ||||||
2026-07-02 | DRTS | Alpha Tau Medical Ltd. | Levy Raphi | CFO | S - Sale | $13.00 | -17,873 | 90,180 | -17% | -$232,397 | ||||||
2026-06-30 | CERS | Cerus Corp | Green Kevin Dennis | CFO | S - Sale | $2.94 | -33,676 | 1,062,188 | -3% | -$99,105 | ||||||
| D | 2026-06-30 | CERS | Cerus Corp | Jayaraman Vivek K | COO | S - Sale+OE | $2.94 | -42,359 | 2,248,877 | -2% | -$124,658 | |||||
2026-06-30 | CERS | Cerus Corp | Jensen Chrystal | GC | S - Sale | $2.94 | -24,329 | 966,657 | -2% | -$71,598 | ||||||
2026-06-30 | CERS | Cerus Corp | Greenman William Mariner | Pres, CEO | S - Sale | $2.94 | -101,919 | 5,053,036 | -2% | -$299,937 | ||||||
| ADM | 2026-06-26 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale+OE | $17.04 | -10,000 | 166,053 | -6% | -$170,387 | |||||
2026-06-30 | NMTC | Neuroone Medical Technologies Corp | Christianson Mark | Market Development Dir | S - Sale | $3.18 | -10,000 | 20,692 | -33% | -$31,773 | ||||||
2026-07-01 | OBIO | Orchestra Biomed Holdings, Inc. | Sherman Darren | See Remarks | S - Sale | $4.27 | -15,000 | 1,169,327 | -1% | -$64,050 | ||||||
2026-07-01 | DRTS | Alpha Tau Medical Ltd. | Levy Raphi | CFO | S - Sale | $13.02 | -2,127 | 90,180 | -2% | -$27,691 | ||||||
| D | 2026-06-29 | CLPT | Clearpoint Neuro, Inc. | Burnett Joseph | CEO, Pres | S - Sale+OE | $19.38 | -20,000 | 308,230 | -6% | -$387,600 | |||||
2026-06-30 | DRTS | Alpha Tau Medical Ltd. | Levy Raphi | CFO | S - Sale | $12.00 | -20,000 | 90,180 | -18% | -$240,044 | ||||||
| DM | 2026-06-26 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale+OE | $17.04 | -10,000 | 165,931 | -6% | -$170,387 | |||||
| D | 2026-05-11 | MOBI | Mobia Medical, Inc. | Green Park & Golf Ventures - Houston, LLC | 10% | P - Purchase | $15.00 | +60,537 | 60,537 | New | +$908,055 | |||||
| D | 2026-05-11 | MOBI | Mobia Medical, Inc. | Green Park & Golf Ventures Ii, LLC | 10% | P - Purchase | $15.00 | +33,333 | 311,112 | +12% | +$499,995 | |||||
| D | 2026-05-11 | MOBI | Mobia Medical, Inc. | Green Park & Golf Ventures Ii, LLC | 10% | S - Sale+OE | $0.00 | -6,731 | 43,799 | -13% | -$0 | |||||
| D | 2026-05-11 | MOBI | Mobia Medical, Inc. | Green Park & Golf Ventures Ii, LLC | 10% | P - Purchase | $15.00 | +81,000 | 81,000 | New | +$1,215,000 | |||||
2026-06-26 | BDX | Becton Dickinson & Co | Feld Michael | EVP, Chief Revenue Officer | S - Sale | $152.80 | -75 | 21,009 | 0% | -$11,460 | ||||||
2026-06-24 | HTFL | Heartflow, Inc. | Farquhar John C.M. | CEO | S - Sale | $35.00 | -38,900 | 457,935 | -8% | -$1,361,500 | ||||||
2026-06-25 | DRTS | Alpha Tau Medical Ltd. | Levy Raphi | CFO | S - Sale | $11.00 | -20,000 | 110,180 | -15% | -$220,004 | ||||||
2026-06-15 | STVN | Stevanato Group S.P.A. | Balachandran Madhavan | Dir | S - Sale | $17.09 | -1,493 | 69,458 | -2% | -$25,515 | ||||||
2026-06-15 | STVN | Stevanato Group S.P.A. | Morel Donald E Jr | Dir | S - Sale | $17.09 | -1,493 | 37,424 | -4% | -$25,515 | ||||||
2026-06-15 | STVN | Stevanato Group S.P.A. | Flynn Karen | Dir | S - Sale | $17.09 | -1,493 | 5,757 | -21% | -$25,515 | ||||||
2026-06-15 | STVN | Stevanato Group S.P.A. | Federici William J | Dir | S - Sale | $17.09 | -1,493 | 58,580 | -2% | -$25,515 | ||||||
2026-06-24 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale | $15.01 | -1,258 | 129,354 | -1% | -$18,880 | ||||||
2026-06-24 | BBNX | Beta Bionics, Inc. | Jones Christy | Dir | S - Sale | $15.00 | -1,406 | 25,994 | -5% | -$21,090 | ||||||
2026-06-23 | DRTS | Alpha Tau Medical Ltd. | Levy Raphi | CFO | S - Sale | $9.55 | -17,500 | 130,180 | -12% | -$167,051 | ||||||
2026-06-24 | BDX | Becton Dickinson & Co | Garrison Michael David | EVP, Pres Med.Essntl, BioPharm | S - Sale | $145.66 | -1,100 | 13,172 | -8% | -$160,226 | ||||||
| M | 2026-06-18 | NXGL | Nexgel, Inc. | Levy Adam R. | CEO | S - Sale | $0.59 | -11,000 | 322,692 | -3% | -$6,519 | |||||
2026-06-17 | WOK | Work Medical Technology Group Ltd | Hrt Financial LP | 10% | P - Purchase | $0.05 | +880,456 | 123,944 | -116% | +$40,501 | ||||||
2026-06-18 | WOK | Work Medical Technology Group Ltd | Hrt Financial LP | 10% | S - Sale | $3.87 | -136,665 | 123,944 | -52% | -$528,894 | ||||||
2026-06-18 | OFIX | Orthofix Medical Inc. | McPherron Aviva | Pres, Global Ops, Qual | S - Sale | $9.38 | -3,670 | 66,330 | -5% | -$34,425 | ||||||
| D | 2026-06-17 | CLPT | Clearpoint Neuro, Inc. | Burnett Joseph | CEO, Pres | S - Sale+OE | $17.79 | -61,843 | 308,230 | -17% | -$1,100,463 | |||||
| D | 2026-06-15 | BWAY | Brainsway Ltd. | Moiseyev Gilad | CTO | S - Sale+OE | $0.00 | -5,000 | 53,098 | -9% | -$0 | |||||
2026-06-16 | GKOS | Glaukos Corp | Navratil Tomas | CHIEF DEVELOPMENT OFFICER | S - Sale | $130.68 | -1,537 | 88,833 | -2% | -$200,855 | ||||||
| D | 2026-06-16 | MDLN | Medline Inc. | Golwas Douglas P | Chief Commercial Officer, 10% | S - Sale+OE | $36.77 | -100,000 | 389,763 | -20% | -$3,677,115 | |||||
2026-06-15 | KMTS | Kestra Medical Technologies, Ltd. | Webster Brian Daniel | See Remarks | S - Sale | $20.81 | -15,000 | 395,467 | -4% | -$312,143 | ||||||
2026-06-15 | DXCM | Dexcom Inc | Brown Michael Jon | EVP Chief Legal Compliance Off | S - Sale | $75.55 | -1,700 | 106,353 | -2% | -$128,435 | ||||||
2026-06-15 | DXCM | Dexcom Inc | Foletta Mark G | Dir | S - Sale | $74.13 | -4,000 | 59,183 | -6% | -$296,540 | ||||||
2026-06-15 | WOK | Work Medical Technology Group Ltd | Hrt Financial LP | 10% | P - Purchase | $0.10 | +268,927 | 391,456 | +219% | +$25,548 | ||||||
2026-06-16 | WOK | Work Medical Technology Group Ltd | Hrt Financial LP | 10% | S - Sale | $0.06 | -2,904,567 | 391,456 | -88% | -$168,465 | ||||||
| M | 2026-06-12 | SI | Shoulder Innovations, Inc. | Ahearn Matthew Fraser | COO | S - Sale | $18.71 | -20,000 | 269,176 | -7% | -$374,255 | |||||
2026-06-12 | WOK | Work Medical Technology Group Ltd | Hrt Financial LP | 10% | P - Purchase | $0.08 | +48,108 | 3,027,096 | +2% | +$3,849 | ||||||
2026-06-15 | CTSO | Cytosorbents Corp | Mariani Peter J | CFO | P - Purchase | $0.44 | +100,000 | 638,113 | +19% | +$44,000 | ||||||
| M | 2026-06-12 | CTSO | Cytosorbents Corp | Chan Phillip P. | CEO | P - Purchase | $0.40 | +261,469 | 1,744,432 | +18% | +$104,898 | |||||
2026-06-12 | GUTS | Fractyl Health, Inc. | Royan Ajay | Dir | P - Purchase | $0.85 | +23,000 | 6,453,102 | 0% | +$19,596 | ||||||
2026-06-11 | NXGL | Nexgel, Inc. | Levy Adam R. | CEO | S - Sale | $0.61 | -3,000 | 333,692 | -1% | -$1,841 | ||||||
2026-06-11 | KRMD | Koru Medical Systems, Inc. | Kalbermatten Adam R | Pres-Chief Commercial Off | P - Purchase | $3.94 | +12,500 | 617,500 | +2% | +$49,275 | ||||||
| M | 2025-12-31 | GIPL | Global Innovative Platforms Inc. | Brown Andrew Nicholas | CEO, CFO, 10% | P - Purchase | $0.06 | +500,000 | 1,081,055 | +86% | +$30,500 | |||||
| D | 2026-06-11 | AORT | Artivion, Inc. | Green Andrew M | SVP, Regulatory, Quality | S - Sale+OE | $20.70 | -44,001 | 60,259 | -42% | -$910,739 | |||||
| D | 2026-06-12 | UFPT | Ufp Technologies Inc | Feldmann Cynthia L | Dir | S - Sale+OE | $239.29 | -1,200 | 5,476 | -18% | -$287,149 | |||||
2026-06-10 | HTFL | Heartflow, Inc. | Farquhar John C.M. | CEO | S - Sale | $28.50 | -22,562 | 496,835 | -4% | -$643,017 | ||||||
2026-06-11 | ATEC | Alphatec Holdings, Inc. | McGinnis Karen K | Dir | S - Sale | $8.01 | -6,050 | 94,671 | -6% | -$48,461 | ||||||
2026-06-11 | NVNO | Envveno Medical Corp | Duhay Francis | Dir | S - Sale | $10.31 | -140 | 2,362 | -6% | -$1,443 | ||||||
| M | 2026-06-10 | WOK | Work Medical Technology Group Ltd | Hrt Financial LP | 10% | P - Purchase | $0.10 | +3,794,711 | 2,978,988 | -465% | +$363,500 | |||||
| AM | 2026-06-10 | TMCI | Treace Medical Concepts, Inc. | Treace John T. | CEO, 10% | P - Purchase | $4.03 | +24,606 | 12,672,568 | 0% | +$99,196 | |||||
2026-06-09 | CERS | Cerus Corp | Bjerkholt Eric | Dir | S - Sale | $2.60 | -20,454 | 261,679 | -7% | -$53,180 | ||||||
2026-06-09 | MOBI | Mobia Medical, Inc. | Curnes Nelson Bunker | CFO | P - Purchase | $12.79 | +5,000 | 932,807 | +1% | +$63,969 | ||||||
2026-06-10 | BDX | Becton Dickinson & Co | Garrison Michael David | EVP, Pres Med.Essntl, BioPharm | S - Sale | $151.48 | -1,100 | 14,272 | -7% | -$166,628 | ||||||
| D | 2026-06-10 | GUTS | Fractyl Health, Inc. | Bradley William | Dir | P - Purchase | $0.73 | +68,493 | 84,622 | +425% | +$50,329 | |||||
| D | 2026-06-10 | GUTS | Fractyl Health, Inc. | Sheffield Ian | Dir | P - Purchase | $0.73 | +35,000 | 35,000 | New | +$25,529 | |||||
2026-06-10 | GUTS | Fractyl Health, Inc. | Rajagopalan Harith | CEO | P - Purchase | $0.73 | +25,000 | 1,143,537 | +2% | +$18,253 | ||||||
| M | 2026-06-10 | TMCI | Treace Medical Concepts, Inc. | Treace John T. | CEO, 10% | P - Purchase | $4.03 | +52,317 | 12,700,279 | 0% | +$210,968 | |||||
2026-06-10 | SGHT | Sight Sciences, Inc. | Encrantz Staffan | Dir, 10% | P - Purchase | $4.88 | +14,100 | 7,153,659 | 0% | +$68,794 | ||||||
| D | 2026-06-09 | PETV | Petvivo Holdings, Inc. | A.L. Sarroff Fund, LLC | 10% | P - Purchase | $0.00 | +187,500 | 10,439,729 | +2% | +$0 | |||||
2026-06-09 | RCEL | Avita Medical, Inc. | Woody Joseph Fralin | Dir | P - Purchase | $4.00 | +5,200 | 107,961 | +5% | +$20,800 | ||||||
2026-06-08 | PRCT | Procept Biorobotics Corp | Nouri Alaleh | EVP, CLO, CORP. SEC. | S - Sale | $28.48 | -285 | 105,069 | 0% | -$8,117 | ||||||
2026-06-08 | PRCT | Procept Biorobotics Corp | Waters Kevin | EVP, CFO | S - Sale | $28.48 | -357 | 151,201 | 0% | -$10,167 | ||||||
2026-06-08 | PRCT | Procept Biorobotics Corp | Templin Barry L | EVP, CTO | S - Sale | $28.48 | -358 | 68,953 | -1% | -$10,195 | ||||||
2026-06-09 | WOK | Work Medical Technology Group Ltd | Hrt Financial LP | 10% | S - Sale | $0.11 | -3,463,022 | 0 | -100% | -$363,617 | ||||||
| M | 2026-06-04 | NXGL | Nexgel, Inc. | Levy Adam R. | CEO | S - Sale | $0.57 | -6,000 | 336,692 | -2% | -$3,422 | |||||
2026-06-08 | GUTS | Fractyl Health, Inc. | Smith Weber Lara | CFO | P - Purchase | $0.69 | +20,000 | 20,000 | New | +$13,708 | ||||||
| D | 2026-06-05 | GMED | Globus Medical Inc | Davidar David D | Dir | S - Sale+OE | $80.76 | -25,000 | 676,142 | -4% | -$2,019,073 | |||||
2026-06-09 | RCEL | Avita Medical, Inc. | Woody Joseph Fralin | Dir | P - Purchase | $4.19 | +10,000 | 102,761 | +11% | +$41,900 | ||||||
2026-06-05 | MDLN | Medline Inc. | Corcoran Jessi L | Principal Accounting Officer | P - Purchase | $34.15 | +5,000 | 5,000 | New | +$170,750 | ||||||
2026-06-08 | WOK | Work Medical Technology Group Ltd | Hrt Financial LP | 10% | P - Purchase | $0.11 | +2,261,118 | 2,647,299 | +586% | +$239,679 | ||||||
| D | 2026-06-08 | RMD | Resmed Inc | Farrell Michael J. | COB, CEO | S - Sale+OE | $193.96 | -4,991 | 468,346 | -1% | -$968,064 | |||||
2026-06-05 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale | $15.25 | -3,575 | 97,130 | -4% | -$54,505 | ||||||
| M | 2026-06-04 | WOK | Work Medical Technology Group Ltd | Hrt Financial LP | 10% | P - Purchase | $0.10 | +1,424,537 | 386,181 | -137% | +$148,922 | |||||
2026-06-04 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale | $12.31 | -275 | 130,612 | 0% | -$3,385 | ||||||
2026-06-04 | BBNX | Beta Bionics, Inc. | Jones Christy | Dir | S - Sale | $14.00 | -2,811 | 27,400 | -9% | -$39,354 | ||||||
2026-06-03 | RCEL | Avita Medical, Inc. | Woody Joseph Fralin | Dir | P - Purchase | $4.09 | +10,000 | 92,761 | +12% | +$40,949 | ||||||
2026-06-04 | NVCR | Novocure Ltd | Leonard Frank X | CEO | S - Sale | $17.93 | -34,273 | 459,520 | -7% | -$614,635 | ||||||
| M | 2026-06-03 | DXCM | Dexcom Inc | Coleman Jon | EVP, Chief Commercial Officer | S - Sale | $73.56 | -9,823 | 95,450 | -9% | -$722,628 | |||||
2026-06-03 | PODD | Insulet Corp | Stonesifer Timothy C. | Dir | P - Purchase | $143.51 | +2,790 | 9,041 | +45% | +$400,393 | ||||||
2026-06-03 | PODD | Insulet Corp | Borio Luciana | Dir | S - Sale | $143.27 | -418 | 4,329 | -9% | -$59,887 | ||||||
2026-06-04 | IRMD | Iradimed Corp | Scharen-Guivel Hilda Frederique | Dir | S - Sale | $95.00 | -3,000 | 5,598 | -35% | -$285,000 | ||||||
| M | 2025-06-30 | GIPL | Global Innovative Platforms Inc. | Brown David A B | 10% | P - Purchase | $0.03 | +6,682,800 | 3,775,612 | -230% | +$202,000 | |||||
2026-06-03 | DRTS | Alpha Tau Medical Ltd. | Levy Raphi | CFO | S - Sale | $10.83 | -32,500 | 147,680 | -18% | -$352,115 | ||||||
2026-06-01 | NXGL | Nexgel, Inc. | Levy Adam R. | CEO | S - Sale | $0.59 | -2,000 | 342,692 | -1% | -$1,172 | ||||||
2026-06-02 | BBNX | Beta Bionics, Inc. | Mensinger Mike | Chief Product Officer | S - Sale | $12.61 | -4,378 | 184,415 | -2% | -$55,194 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |